• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Theorem optimizes services for regulatory and clinical issues

Theorem optimizes services for regulatory and clinical issues

October 10, 2012
CenterWatch Staff

Theorem Clinical Research, a King of Prussia, Penn.-based full-service CRO that provides core clinical R&D services, also helps clients identify and strategically address early and ongoing device-related regulatory and clinical issues.

Theorem develops clinical study protocol and design for pre-Investigational Device Exemption (pre-IDE) activities, IDE submissions and IRB review and approval. The goals of these services are both to optimize medical clients' pathway to marketability and to ensure their high-quality adherence to all post-marketing requirements, said Evan L. Rosenfeld, vice president of medical and scientific affairs, medical devices and diagnostics, Theorem.

“The traditional CRO doesn’t offer a full spectrum of regulatory services,” Rosenfeld said. “At Theorem, we go above and beyond to help our clients focus on the regulatory processes in addition to tactical protocol development and then running their clinical trials.”

Theorem offers a strategic clinical and regulatory approach to pave the best pathway for such efforts, from original trial design to study start, through FDA and IRB review and approval, and ultimately to market entry.

With the FDA’s greater emphasis on post-marketing surveillance and trials, Theorem also provides additional trial setup for its clients and saves time in those respects.

“We help our clients meet both the FDA’s requirements for post-marketing surveillance and also the evidentiary requirements that insurance companies may impose for product reimbursement,” Rosenfeld said.

Theorem’s process for pre-IDE services includes a thorough review of the relevant regulatory provisions and guidance documents, analysis of relevant research in the field, review of the past outcomes for similar devices and a determination of the studies that may be required for both regulatory market entry and subsequent insurance coverage.

    Upcoming Events

    • 16Oct

      MAGI@home Clinical Research Conference 2023

    • 25Oct

      2023 WCG Patient Forum

    • 26Oct

      FDA in 2024: What to Expect in an Election Year

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Donna Snyder

      New WCG Executive Physician Outlines Goals for Clinical Research

    • Hand Shake at Meeting

      Partnership to Bolster Trials in Low Resource Regions Kicks Off

    • Guidelines-360x240.png

      Major Industry Groups Offer Feedback on ICH’s E6(R3) Guidelines

    • AsktheExpertsBadge-360x240.png

      Ask the Experts: Monitoring

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing